Concord Medical Services Holdings (CCM) EBIT (2009 - 2025)

Concord Medical Services Holdings (CCM) has reported EBIT for 17 consecutive years, with -$20.0 million the latest figure, recorded in Q2 2025.

• EBIT for Q2 2025 came in at -$20.0 million, up 26.79% year-over-year; the trailing twelve-month figure through Jun 2025 was -$115.1 million (up 6.86% YoY), and the FY2025 annual result was -$13.9 million, up 81.3% from the prior year.
• EBIT was -$20.0 million for Q2 2025 at Concord Medical Services Holdings, up from -$27.3 million in the prior quarter.
• Over five years, EBIT peaked at -$20.0 million in Q2 2025 and troughed at -$37.2 million in Q2 2022.
• Average EBIT over 5 years is -$28.7 million, with a median of -$28.5 million recorded in 2021.
• Year-over-year, EBIT slumped 30.77% in 2022 and advanced 26.79% in 2025.
• Over 5 years, EBIT stood at -$28.5 million in 2021, then slumped by 30.77% to -$37.2 million in 2022, then climbed by 17.96% to -$30.6 million in 2023, then advanced by 10.61% to -$27.3 million in 2024, then advanced by 26.79% to -$20.0 million in 2025.
• Per Business Quant data, the three most recent EBIT figures were -$20.0 million in Q2 2025, -$27.3 million in Q2 2024, and -$30.6 million in Q2 2023.